466 related articles for article (PubMed ID: 32920952)
1. Comparison of antifungal and cytotoxicity activities of titanium dioxide and zinc oxide nanoparticles with amphotericin B against different Candida species: In vitro evaluation.
Ahmadpour Kermani S; Salari S; Ghasemi Nejad Almani P
J Clin Lab Anal; 2021 Jan; 35(1):e23577. PubMed ID: 32920952
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of antifungal and cytotoxic activities as also the therapeutic safety of the oxidized form of amphotericin B.
Klimek K; Strubińska J; Czernel G; Ginalska G; Gagoś M
Chem Biol Interact; 2016 Aug; 256():47-54. PubMed ID: 27350166
[TBL] [Abstract][Full Text] [Related]
3. ZnO, TiO2 and Ag nanoparticles impact against some species of pathogenic bacteria and yeast.
Mohammed AK; Salh KK; Ali FA
Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):24-34. PubMed ID: 34933736
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cytogenotoxicity and oxidative stress parameters in male Swiss mice co-exposed to titanium dioxide and zinc oxide nanoparticles.
Fadoju O; Ogunsuyi O; Akanni O; Alabi O; Alimba C; Adaramoye O; Cambier S; Eswara S; Gutleb AC; Bakare A
Environ Toxicol Pharmacol; 2019 Aug; 70():103204. PubMed ID: 31200344
[TBL] [Abstract][Full Text] [Related]
5. Enhanced antifungal effects of amphotericin B-TPGS-b-(PCL-ran-PGA) nanoparticles in vitro and in vivo.
Tang X; Zhu H; Sun L; Hou W; Cai S; Zhang R; Liu F
Int J Nanomedicine; 2014; 9():5403-13. PubMed ID: 25473279
[TBL] [Abstract][Full Text] [Related]
6. Antifungal Activity of Chitosan-Coated Poly(lactic-co-glycolic) Acid Nanoparticles Containing Amphotericin B.
Ludwig DB; de Camargo LEA; Khalil NM; Auler ME; Mainardes RM
Mycopathologia; 2018 Aug; 183(4):659-668. PubMed ID: 29497926
[TBL] [Abstract][Full Text] [Related]
7. Invitro antifungal susceptibilities of Candida species to liposomal amphotericin B, determined using CLSI broth microdilution, and amphotericin B deoxycholate, measured using the Etest.
Lovero G; Giglio O; Rutigliano S; Diella G; Caggiano G; Montagna MT
J Med Microbiol; 2017 Mar; 66(2):213-216. PubMed ID: 27959780
[TBL] [Abstract][Full Text] [Related]
8. [In vitro amphotericin B susceptibility of korean bloodstream yeast isolates assessed by the CLSI broth microdilution method, Etest, and Minimum fungicidal concentration test].
Park JY; Shin JH; Uh Y; Kim EC; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW
Korean J Lab Med; 2008 Oct; 28(5):346-52. PubMed ID: 18971615
[TBL] [Abstract][Full Text] [Related]
9. Genotoxic effects of zinc oxide nanoparticles in nasal mucosa cells are antagonized by titanium dioxide nanoparticles.
Hackenberg S; Scherzed A; Zapp A; Radeloff K; Ginzkey C; Gehrke T; Ickrath P; Kleinsasser N
Mutat Res Genet Toxicol Environ Mutagen; 2017 Apr; 816-817():32-37. PubMed ID: 28464994
[TBL] [Abstract][Full Text] [Related]
10. Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
Lass-Flörl C; Mayr A; Perkhofer S; Hinterberger G; Hausdorfer J; Speth C; Fille M
Antimicrob Agents Chemother; 2008 Oct; 52(10):3637-41. PubMed ID: 18694949
[TBL] [Abstract][Full Text] [Related]
11. Water-soluble amphotericin B-polyvinylpyrrolidone complexes with maintained antifungal activity against Candida spp. and Aspergillus spp. and reduced haemolytic and cytotoxic effects.
Charvalos E; Tzatzarakis MN; Van Bambeke F; Tulkens PM; Tsatsakis AM; Tzanakakis GN; Mingeot-Leclercq MP
J Antimicrob Chemother; 2006 Feb; 57(2):236-44. PubMed ID: 16361329
[TBL] [Abstract][Full Text] [Related]
12. Physiological and histopathological alterations in male Swiss mice after exposure to titanium dioxide (anatase) and zinc oxide nanoparticles and their binary mixture.
Ogunsuyi O; Ogunsuyi O; Akanni O; Alabi O; Alimba C; Adaramoye O; Cambier S; Eswara S; Gutleb AC; Bakare A
Drug Chem Toxicol; 2022 May; 45(3):1188-1213. PubMed ID: 32865034
[TBL] [Abstract][Full Text] [Related]
13. Patterns of amphotericin B killing kinetics against seven Candida species.
Cantón E; Pemán J; Gobernado M; Viudes A; Espinel-Ingroff A
Antimicrob Agents Chemother; 2004 Jul; 48(7):2477-82. PubMed ID: 15215097
[TBL] [Abstract][Full Text] [Related]
14. Survey of amphotericin B susceptibility of Candida clinical isolates determined by Etest.
Chiu YS; Chang SC; Hsueh PR; Wang JL; Sun HY; Chen YC
J Microbiol Immunol Infect; 2006 Aug; 39(4):335-41. PubMed ID: 16926981
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro antifungal susceptibility activity of amphotericin B versus amphotericin B methyl ester against Candida albicans ocular isolates.
Thanathanee O; Miller D; Ringel DM; Schaffner CP; Alfonso EC; O'Brien TP
J Ocul Pharmacol Ther; 2012 Dec; 28(6):589-92. PubMed ID: 22788845
[TBL] [Abstract][Full Text] [Related]
16. Antifungal effects of ZnO, TiO
Najibi Ilkhechi N; Mozammel M; Yari Khosroushahi A
Pestic Biochem Physiol; 2021 Jul; 176():104869. PubMed ID: 34119214
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species.
Moore CB; Oakley KL; Denning DW
Clin Microbiol Infect; 2001 Jan; 7(1):11-6. PubMed ID: 11284
